Stoke Therapeutics
ID: 5330868Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.
3
Funding Rounds
$235.1m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Is**** Az***** | - | - | linkedin twitter |
| Ed**** Ka** | - | - | |
| Hu* Na** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ed**** Ka** | - | - | |
| Je****** Bu****** | - | - | - |
| Ar**** Le*** | - | - | - |
| Ar**** Tz******* | - | - | |
| Se** L. Ha****** | - | - | - |
| Ga*** Me**** | - | - |
Funding series
Funding Series Analysis
The company Stoke Therapeutics has raised a total of $40m in funding over 3 rounds.
Key Insights:
- Stoke Therapeutics Series A round, January 2017: $40m
- Stoke Therapeutics Venture round, November 2020: $105.1m
- Stoke Therapeutics funding round, October 2018: $90m
Industries
Stoke Therapeutics is active in the following industries: